Nephron sparing surgery has excellent lasting outcomes
(HealthDay)—For patients with bilateral renal masses, nephron sparing surgery (NSS) results in excellent long-term oncological and functional outcomes and survival rates, according to a study published ...
Surgery
Nov 19, 2012 |
not rated yet |
0
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Novel cell growth factor for preventing and treating injury caused by high-level radiation exposure
Japanese researchers have created novel cell growth factor FGFC that is considered effective in preventing and treating injury due to high-dose radiation. Until now, there have been insufficient drugs effective ...
Medical research
Nov 02, 2012 |
5 / 5 (1) |
0
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
UNM Cancer Center researcher looks for genetic markers for ovarian cancer
Ovarian cancer is a deadly disease. With no overt symptoms and no screening tests to catch it early, ovarian cancer is often detected at stage 3 or later. By then, it can be very aggressive and may have spread beyond the ...
Cancer
Oct 23, 2012 |
not rated yet |
0
Statins may help prolong survival in NSCLC resection
Patients who have undergone resection for non-small cell lung cancer (NSCLC) may improve their overall survival and reduce the risk of recurrence by taking statins.
Cancer
Oct 22, 2012 |
not rated yet |
0
Father of bone marrow transplant is dead at 92
E. Donnall Thomas, a physician who pioneered bone marrow transplants and later won the 1990 Nobel Prize in medicine, has died in Seattle at age 92.
Other
Oct 21, 2012 |
not rated yet |
0
Stat5 predicts outcomes for prostate cancer patients after radical prostatectomy
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of ...
Cancer
Oct 16, 2012 |
not rated yet |
1
Scientists block stomach tumor growth
(Medical Xpress)—Monash Institute of Medical Research scientists may have discovered a way of blocking stomach tumours from growing and spreading, according to a paper published in the highly-prestigious ...
Cancer
Oct 16, 2012 |
1 / 5 (1) |
0
Transcription factor Prox1 controls hippocampal cellular diversity, researchers find
As is true of many brain structures, the hippocampus, which plays a central role in memory and learning, is made up of multiple cell types organized into domains controlling different functions. Distinct ...
Neuroscience
Oct 16, 2012 |
not rated yet |
0
New study moves researchers closer to lung cancer blood test
Early signs of lung cancer could be diagnosed using a simple blood test following a new discovery by scientists at the University of York.
Cancer
Oct 15, 2012 |
5 / 5 (1) |
0
|
Study supports link between obesity and higher incidence of cancer, poorer prognosis
Researchers may have discovered a new explanation as to why obese patients with cancer often have a poorer prognosis compared with those who are lean. The potential explanation is based on data reported in Cancer Research, a jour ...
Cancer
Oct 15, 2012 |
not rated yet |
0
3-D model for lung cancer mimics the real thing
(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research ...
Cancer
Oct 11, 2012 |
4 / 5 (1) |
0
Genetic risk for uterine fibroids discovered
Uterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk ...
Genetics
Oct 04, 2012 |
not rated yet |
0
Breakthrough in understanding lung cancer vulnerabilities points the way to new targeted therapy
More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study.
Cancer
Oct 01, 2012 |
5 / 5 (5) |
0
|
